717-1344

completed

Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
717 (USA) · Dr. Reyes
consented 2014-01-11

AEs

Serious

Dropout signal

–

Adverse events

mild assessed

Mild FATIGUE — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-02-01 (study day 22.0); relationship: POSSIBLE

mild assessed

Mild FATIGUE — outcome: RECOVERED/RESOLVED; onset 2014-02-01 (study day 22.0); relationship: POSSIBLE

mild assessed

Mild NASAL CONGESTION — outcome: RECOVERED/RESOLVED; onset 2014-02-01 (study day 22.0); relationship: REMOTE

moderate assessed

Moderate NAUSEA — outcome: RECOVERED/RESOLVED; onset 2014-02-28 (study day 49.0); relationship: REMOTE

moderate assessed

Moderate VOMITING — outcome: RECOVERED/RESOLVED; onset 2014-02-28 (study day 49.0); relationship: REMOTE

Data queries

No data queries.